Loading…
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man
The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid...
Saved in:
Published in: | Gut 1984-07, Vol.25 (7), p.707-710 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403 |
---|---|
cites | cdi_FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403 |
container_end_page | 710 |
container_issue | 7 |
container_start_page | 707 |
container_title | Gut |
container_volume | 25 |
creator | Howden, C W Forrest, J A Reid, J L |
description | The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing. |
doi_str_mv | 10.1136/gut.25.7.707 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1432608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81120281</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403</originalsourceid><addsrcrecordid>eNp9kc2LFDEQxYMo67h68yo0KHqxx1TS6aQvgo7rBywrgnrwYKhO0mPG7k6bdIv615vdGQb14Kko3q8er3iE3AW6BuD1k-0yr5lYy7Wk8hpZQVWrkjOlrpMVpSBLIavmJrmV0o5SqlQDJ-SkrphqFKzI57Ouc2ZOReiK5Mdt7wocbRHd5HB2trAhuSsxDG6K-CtkIIzFFtMcvSnQeHt1MLkpnxfJmehmn4m8DDjeJjc67JO7c5in5MPLs_eb1-X521dvNs_Oy1ZINpcKpLNoRSVEJ60EbIC3ja3alvHWUiO6qpFAbQst6ypOLVjMDxiBtaJYUX5Knu59p6UdnDVunCP2eop-wPhTB_T6b2X0X_Q2fNdQcVZTlQ0eHgxi-La4NOvBJ-P6HkcXlqQVAKNMQQbv_wPuwhLH_JwGKSmtOZOXeR7vKRNDStF1xyhA9WVrOremmdBS59Yyfu_P-Ef4UFPWHxx0TAb7LuJofDpiDdBGcJ6xco_5NLsfRxnjV11LLoW--LjRL9i75xvxieqLzD_a8-2w-3_A39uSvDE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770063270</pqid></control><display><type>article</type><title>Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man</title><source>PubMed Central</source><creator>Howden, C W ; Forrest, J A ; Reid, J L</creator><creatorcontrib>Howden, C W ; Forrest, J A ; Reid, J L</creatorcontrib><description>The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.25.7.707</identifier><identifier>PMID: 6428981</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Adult ; Anti-Ulcer Agents - pharmacology ; Benzimidazoles - pharmacology ; Biological and medical sciences ; Digestive system ; Dose-Response Relationship, Drug ; Gastric Acid - metabolism ; Humans ; Male ; Medical sciences ; Omeprazole ; Pentagastrin - pharmacology ; Pepsin A - metabolism ; Pharmacology. Drug treatments ; Secretory Rate - drug effects</subject><ispartof>Gut, 1984-07, Vol.25 (7), p.707-710</ispartof><rights>1985 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Jul 1984</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403</citedby><cites>FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1432608/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1432608/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9109533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6428981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Howden, C W</creatorcontrib><creatorcontrib>Forrest, J A</creatorcontrib><creatorcontrib>Reid, J L</creatorcontrib><title>Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man</title><title>Gut</title><addtitle>Gut</addtitle><description>The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing.</description><subject>Adult</subject><subject>Anti-Ulcer Agents - pharmacology</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Digestive system</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gastric Acid - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Omeprazole</subject><subject>Pentagastrin - pharmacology</subject><subject>Pepsin A - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Secretory Rate - drug effects</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><recordid>eNp9kc2LFDEQxYMo67h68yo0KHqxx1TS6aQvgo7rBywrgnrwYKhO0mPG7k6bdIv615vdGQb14Kko3q8er3iE3AW6BuD1k-0yr5lYy7Wk8hpZQVWrkjOlrpMVpSBLIavmJrmV0o5SqlQDJ-SkrphqFKzI57Ouc2ZOReiK5Mdt7wocbRHd5HB2trAhuSsxDG6K-CtkIIzFFtMcvSnQeHt1MLkpnxfJmehmn4m8DDjeJjc67JO7c5in5MPLs_eb1-X521dvNs_Oy1ZINpcKpLNoRSVEJ60EbIC3ja3alvHWUiO6qpFAbQst6ypOLVjMDxiBtaJYUX5Knu59p6UdnDVunCP2eop-wPhTB_T6b2X0X_Q2fNdQcVZTlQ0eHgxi-La4NOvBJ-P6HkcXlqQVAKNMQQbv_wPuwhLH_JwGKSmtOZOXeR7vKRNDStF1xyhA9WVrOremmdBS59Yyfu_P-Ef4UFPWHxx0TAb7LuJofDpiDdBGcJ6xco_5NLsfRxnjV11LLoW--LjRL9i75xvxieqLzD_a8-2w-3_A39uSvDE</recordid><startdate>19840701</startdate><enddate>19840701</enddate><creator>Howden, C W</creator><creator>Forrest, J A</creator><creator>Reid, J L</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19840701</creationdate><title>Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man</title><author>Howden, C W ; Forrest, J A ; Reid, J L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adult</topic><topic>Anti-Ulcer Agents - pharmacology</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Digestive system</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gastric Acid - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Omeprazole</topic><topic>Pentagastrin - pharmacology</topic><topic>Pepsin A - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Secretory Rate - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Howden, C W</creatorcontrib><creatorcontrib>Forrest, J A</creatorcontrib><creatorcontrib>Reid, J L</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Howden, C W</au><au>Forrest, J A</au><au>Reid, J L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1984-07-01</date><risdate>1984</risdate><volume>25</volume><issue>7</issue><spage>707</spage><epage>710</epage><pages>707-710</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>6428981</pmid><doi>10.1136/gut.25.7.707</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-5749 |
ispartof | Gut, 1984-07, Vol.25 (7), p.707-710 |
issn | 0017-5749 1468-3288 1458-3288 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1432608 |
source | PubMed Central |
subjects | Adult Anti-Ulcer Agents - pharmacology Benzimidazoles - pharmacology Biological and medical sciences Digestive system Dose-Response Relationship, Drug Gastric Acid - metabolism Humans Male Medical sciences Omeprazole Pentagastrin - pharmacology Pepsin A - metabolism Pharmacology. Drug treatments Secretory Rate - drug effects |
title | Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A14%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20single%20and%20repeated%20doses%20of%20omeprazole%20on%20gastric%20acid%20and%20pepsin%20secretion%20in%20man&rft.jtitle=Gut&rft.au=Howden,%20C%20W&rft.date=1984-07-01&rft.volume=25&rft.issue=7&rft.spage=707&rft.epage=710&rft.pages=707-710&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.25.7.707&rft_dat=%3Cproquest_pubme%3E81120281%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b572t-817edad5455f7d71a913b9d4bb23bd0c5f49710db1b2f430d1da289c5a680a403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770063270&rft_id=info:pmid/6428981&rfr_iscdi=true |